Straumann Holding AG stock (CH0012280076): shares ease on SIX amid modest SPI weakness

Straumann Holding AG shares traded slightly lower on the SIX Swiss Exchange on 06/01/2026, underperforming a soft Swiss Performance Index in a quiet news session for the dental implant specialist.

Straumann Holding AG shares traded slightly lower on the SIX Swiss Exchange on 06/01/2026, with the stock quoted around 94.00 CHF by late morning trading and lagging a mildly weaker Swiss Performance Index, according to finanzen.ch as of 06/01/2026.

Market data from finanzen.ch showed the Straumann share at 94.02 CHF at 09:28 CET and 94.04 CHF at 12:28 CET on SIX, each representing an intraday decline of about 0.7 percent and placing the stock among the weaker names in the SPI on the day.

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Straumann
• Sector/industry: Dental implants and orthodontic medical technology
• Headquarters/country: Basel, Switzerland
• Core markets: Europe, North America, Asia-Pacific and Latin America
• Key revenue drivers: Dental implant systems, orthodontic solutions including clear aligners, digital dentistry workflows and services
• Home exchange/listing venue: SIX Swiss Exchange (STMN)
• Trading currency: CHF

Straumann Holding AG: core business model

Straumann focuses on premium and value-positioned dental implants, orthodontic solutions and digitally enabled dental workflows that generate revenue through the sale of implant systems, clear aligners, biomaterials, instruments and related services to dentists and dental laboratories worldwide.

What banks and research houses say about Straumann Holding AG

No verified analyst coverage was identified at the time of publication.

Conclusion

The modest decline in Straumann Holding AG shares on SIX on 06/01/2026 reflects a softer session for parts of the Swiss market rather than a specific new company disclosure. In the absence of fresh analyst commentary or corporate news, short-term moves are likely driven by broader sentiment toward healthcare and medical technology names. Investors will watch for upcoming company communications or sector data points to reassess the stock's relative position within the Swiss and global dental technology space.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.